Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;84(16):1515-1524.
doi: 10.1002/pros.24792. Epub 2024 Sep 15.

Diagnostic potential of SDHB mRNA contained in serum extracellular vesicles among patients with prostate cancer

Taku Kato  1   2 , Eiji Sugihara  3 , Yuko Hata  3 , Kyojiro Kawakami  4 , Yasunori Fujita  5 , Kosuke Mizutani  6 , Tatsuya Ando  1 , Yasuhiro Sakai  1   7 , Kouhei Sakurai  1 , Shohei Toyota  2 , Hidetoshi Ehara  2 , Masafumi Ito  4 , Hiroyasu Ito  1
Affiliations

Diagnostic potential of SDHB mRNA contained in serum extracellular vesicles among patients with prostate cancer

Taku Kato et al. Prostate. 2024 Dec.

Abstract

Background: Androgen receptor signaling inhibitors(ARSIs) have been used to treat patients with metastatic prostate cancer (PC) and castration-resistant prostate cancer (CRPC). In this study, we aimed to identify novel serum extracellular vesicle (EV)-based biomarkers to diagnose ARSI-resistance and therapeutic targets for ARSI-resistant CRPC.

Methods: Total RNA contained in serum EVs from 5 cases of CRPC before ARSI treatment and after acquiring ARSI-resistance was subjected to RNA-sequencing. The expression changes of selected RNAs contained in EVs were confirmed in 48 cases of benign prostatic hyperplasia (BPH) and 107 PC using reverse transcription-quantitative PCR (RT-qPCR) and compared with tissue RNA expression using public datasets.

Results: RNA-sequencing revealed that mitochondrial oxidative phosphorylation (OXPHOS)-related genes were increased in EVs after acquiring ARSI-resistance. Among them, RT-qPCR and datasets analysis demonstrated that SDHB mRNA was upregulated after acquiring ARSI-resistance in EVs and ARSI-exposed PC tissue compared to ARSI-naïve EVs and tissue, respectively. SDHB mRNA levels both in EVs and tissue were increased in localized PC compared with BPH and decreased in advanced PC. Tissue expression of SDHB mRNA was significantly correlated with those of other OXPHOS-related genes. SDHB mRNA in EVs (EV-SDHB) was elevated among 3 out of 7 ARSI-treating patients with stable PSA levels who later progressed to ARSI-resistant CRPC.

Conclusions: The levels of OXPHOS-related mRNAs in EVs correlated with those in PC tissue, among which SDHB mRNA was found to be a novel biomarker to diagnose ARSI-resistance. EV-SDHB may be useful for early diagnosis of ARSI-resistance.

Keywords: CRPC; SDHB; androgen signaling inhibitors; extracellular vesicles.

PubMed Disclaimer

References

REFERENCES

    1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209‐249.
    1. Schaeffer EM, Srinivas S, Adra N, et al. NCCN guidelines® insights: prostate cancer, version 1.2023. J Natl Comprehensive Cancer Network: JNCCN. 2022;20(12):1288‐1298.
    1. Schaeffer EM, Srinivas S, Adra N, et al. Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology. J Natl Comprehensive Cancer Network. 2023;21(10):1067‐1096.
    1. Chen Y, Zhou Q, Hankey W, Fang X, Yuan F. Second generation androgen receptor antagonists and challenges in prostate cancer treatment. Cell Death Dis. 2022;13(7):632.
    1. Zhao SG, Sperger JM, Schehr JL, et al. A clinical‐grade liquid biomarker detects neuroendocrine differentiation in prostate cancer. J Clin Invest. 2022;132(21):e161858.

MeSH terms

LinkOut - more resources